Eucalyptus Suppositories Children

Produit de santé naturel homologué au Canada

Titulaire: JAMP Pharma Corporation
NPN ou DIN-HM: 80047394
Statut: Licence active
Date de licence: 20 décembre 2013
Date de révision: Non renseignée
Forme: Suppositoire
Voie d'administration: Rectale
Type de demande: Non traditionnelle

L’analyse des doses orales ne s’applique pas sans voie exclusivement orale établie.

Composition

Ingrédient médicinal et source	Par unité posologique, selon la source
1,3,3-triméthyl-2-oxabicyclo(2.2.2)octane Source : Eucalyptol	185 mg

Ingrédients non médicinaux

Paraffine

Doses recommandées au Canada

Population	Âge	Quantité par prise	Fréquence
Enfants	Non précisée	minimum : 1 suppositoire ; maximum : 2 suppositoire	1 jour

Usages autorisés au Canada

As an expectorant to relieve cough associated with colds and/or bronchitis. Helps to remove mucous from the upper respiratory tract caused by colds.

Un usage autorisé au Canada n'est pas une allégation de santé autorisée dans l'Union européenne. Consultez le registre des allégations de santé.

Mises en garde au Canada

Précautions et mises en garde
For external use only. Avoid contact with the eyes and mucous membranes. Do not apply to wounds or damaged skin. Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. Overdose may result in serious harm. Do not exceed the single or maximum daily dose because this will increase the risk of adverse drug reactions including convulsions and rectal bleeding. Do not use in children with a recent history of epilepsy or febrile convulsions, or with a recent history of anorectal lesions. Do not use for longer than 3 days due to the possible risks related to accumulation of eucalyptol and camphor in the body including the brain, in particular neuropsychological disorders; and the risk of rectal burning. Do not give with any other cough and cold medications since harm may occur, unless recommended by a healthcare practitioner. Consult a healthcare practitioner prior to use if you: have persistent or chronic cough, difficulty breathing, asthma or other chronic lung conditions, unless directed by a physician. Consult a healthcare practitioner prior to combining with other medications, including natural health products, prescription drugs or non-prescription drugs. Consult a healthcare practitioner if symptoms worsen, last for more than a week or are accompanied by a high fever (>38o C) or the production of thick yellow/green phlegm. Consult a health care practitioner promptly in case of rectal bleeding.
Effets indésirables connus
Rashes and/or burning discomfort have been known to occur; in which case, discontinue use. Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use. Other side effects may include: breathing difficulties, convulsions, drowsiness, hallucinations, and rapid heart rate